Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
150%(3 trials)
Terminated
1(20%)

Phase Distribution

Ph early_phase_1
1
20%
Ph phase_2
3
60%
Ph phase_4
1
20%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)

Detailed Status

Completed2
Recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (20.0%)
Phase 23 (60.0%)
Phase 41 (20.0%)

Trials by Status

completed240%
recruiting120%
withdrawn120%
terminated120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
OTHER
Total Trials
5